House committees to investigate new Alzheimer’s disease drug approval
FDA approved Aduhelm earlier this month, despite advisory committee’s conclusion that there was not enough evidence to support its effectiveness
HealthDay News
COVID-19 falls from America’s No. 1 killer to No. 7 by June
(HealthDay News) — A steep rise in vaccination rates has dropped COVID-19 from the first to the seventh leading cause of death in the United States, a new analysis shows. The disease was the third leading cause of death for much of 2020, but became the leading cause of death in December 2020 and early…
Physician knowledge linked to less opioid prescribing in 2015 to 2017
(HealthDay News) — During 2015 to 2017, physician knowledge was associated with less frequent prescribing of opioids for back pain, according to a study published online July 1 in JAMA Network Open. Bradley M. Gray, Ph.D., from the American Board of Internal Medicine in Philadelphia, and colleagues compared the correlation of clinical knowledge with opioid…
Prediction model for brain age may help detect cognitive decline
Greater differences between predicted age based on brain MRI and actual age seen in those with amnestic MCI versus healthy controls
Low exercise may amplify link between poor sleep, mortality risk
(HealthDay News) — Poor sleep is associated with increased risks of all-cause and cause-specific mortality, with risk exacerbated among those with insufficient physical activity (PA), according to a study published online June 29 in the British Journal of Sports Medicine. Bo-Huei Huang, from the University of Sydney, and colleagues examined the joint association of PA…
Strategies ID’d that can interrupt spread of infectious disease
Key elements of effective system include border controls, restricted entry, quarantine for inbound travelers
Dietary patterns may affect risk for sudden cardiac death
Greater adherence to Southern dietary pattern linked to higher risk for sudden cardiac death, but the association was not statistically significant
Medication type for T2DM may affect severe COVID-19 outcomes
(HealthDay News) — The use of certain classes of diabetes medications prior to severe COVID-19 infection is associated with lower mortality in patients with diabetes, according to a study published online June 16 in Diabetes Care. Anna R. Kahkoska, Ph.D., from the University of North Carolina at Chapel Hill, and colleagues compared premorbid glucagon-like peptide-1…
ADA: Tirzepatide non-inferior, superior to Semaglutide for T2DM
Greater reduction in glycated hemoglobin levels and improved weight loss seen with tirzepatide in type 2 diabetes
ADA: Efpeglenatide lowers risk for adverse CV events in T2DM
(HealthDay News) — For patients with type 2 diabetes and a history of cardiovascular disease or current kidney disease, the risk for adverse cardiovascular events is lower with efpeglenatide, an exendin-based glucagon-like peptide 1 receptor agonist, than placebo, according to a study published online June 28 in the New England Journal of Medicine to coincide…
Heart failure linked to increased incidence of cancer
Increased rates of cancer seen among women and men and for cancer at multiple sites, including lip, oral cavity, pharynx, respiratory organs
LA County recommends masks for all when indoors as Delta variant spreads
First identified in India, the Delta variant is now the third-most common in California
Mental health conditions up in public health workers during pandemic
53.0 percent in public health departments reported symptoms of at least one condition in survey conducted during March, April 2021
Less than 1 percent of COVID-19 patients experience reinfection
Symptoms of severe disease less frequent with reinfection, although death can occur
Rehospitalization in dementia patients tied to nurse continuity
Wide variation seen in continuity of nursing staff for home health care visits to dementia patients following hospitalization
Add-on PPI therapy may improve glycemic control in diabetes
However, treatment with proton pump inhibitors is not associated with risk for incident diabetes in the general population
Post-COVID-19 symptoms are common, affecting 23.2 percent
50 percent of patients hospitalized with COVID-19 and 19 percent of asymptomatic patients had at least one post-COVID-19 condition
Patients do not improve activity level after hip replacement
Findings despite surgery success in aiding pain, physical performance
Few clinicians talk about bariatric surgery with obese patients
But having this discussion is associated with more weight loss and higher odds of bariatric surgery
Want to read more?
Please login or register first to view this content.